-+ 0.00%
-+ 0.00%
-+ 0.00%

Boundless Bio Inc. publishes corporate presentation on ecDNA-directed cancer therapies and BBI-940 Phase 1 trial

Reuters·03/09/2026 11:59:26

Please log in to view news